Adenosine has anti-hypertrophic and anti-adrenergic functions, and adenosine A1 receptors could be considered as potential targets for therapeutic strategies to prevent transition from compensated myocardial hypertrophy to decompensated HF due to chronic cardiac pressure overload [21]. This evidence concerns the gene ADORA1 and cardiac hypertrophy.